Evidence map›Paper›PMID 42627481›Full record

ReviewReproductive sciences (Thousand Oaks, Calif.)2026

Potential and Challenges of Menstrual Blood-derived Mesenchymal Stem Cells/Stromal Cells in Treating Female Infertility: A Recent Review.

Min Chen, Jinqiao Wu, Siqi Tang, Yuehui Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Min ChenHeilongjiang University of Chinese Medicine, No. 24 Heping Road, Xiangfang District, Harbin, Heilongjiang, 150040, China.
Jinqiao WuHeilongjiang University of Chinese Medicine, No. 24 Heping Road, Xiangfang District, Harbin, Heilongjiang, 150040, China.
Siqi TangHeilongjiang University of Chinese Medicine, No. 24 Heping Road, Xiangfang District, Harbin, Heilongjiang, 150040, China.
Yuehui ZhangThe First Affiliated Hospital of Heilongjiang University of Chinese Medicine, No. 26 Heping Road, Xiangfang District, Harbin, Heilongjiang, 150040, China. chizishui-04@163.com.ORCID http://orcid.org/0000-0001-8517-7603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Menstrual blood-derived mesenchymal stem cells/stromal cells (MenSCs) are a new category of stem cells detected in female menstrual blood. They exhibit significant potential for disease treatment owing to their fast proliferation rate and capacity to differentiate into a variety of cell types, ease of collection, capacity for repeated non-invasive sampling, and minimal immunological rejection. This article examines the origin of MenSCs, their characteristics, and the most recent studies on their potential to address female infertility and enhance assisted reproductive outcomes. The objective is to propose innovative applications of stem cells for addressing female infertility.

Indexed as

Assisted reproductive technologyFemale infertilityMenstrual blood-derived mesenchymal stem cells/stromal cellsOvaryResearch progressUterus

Identifiers

PMID42627481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.